A detailed history of Scarborough Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Scarborough Advisors, LLC holds 1,477 shares of JNJ stock, worth $228,994. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,477
Holding current value
$228,994
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$145.48 - $167.38 $214,873 - $247,220
1,477 New
1,477 $239,000
Q4 2023

Feb 29, 2024

BUY
$145.6 - $158.88 $210,246 - $229,422
1,444 New
1,444 $226,000
Q3 2023

Nov 30, 2023

SELL
$155.75 - $174.48 $174,128 - $195,068
-1,118 Reduced 43.69%
1,441 $224,000
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $207,614 - $232,581
1,333 Added 108.73%
2,559 $398,000
Q2 2023

Sep 07, 2023

BUY
$154.35 - $166.11 $189,233 - $203,650
1,226 New
1,226 $202,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.